Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Past 7 days
    • Any time
    • Past hour
    • Past 24 hours
    • Past 30 days
The Lancet
5d

[89 Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

Copyright: © 2024 The Author(s). Published by Elsevier Ltd.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

S&P 500 tumbles 2.7%
Blast at TN explosives plant
Begins laying off workers
ISR: Ceasefire now in effect
'Matlock' actor fired
Deployment paused in IL
Wins Nobel Peace Prize
Georgia woman arrested
Arturo Gatti Jr. dies
Trump threatens tariff hike
Indicted on fraud charge
Asks to block judgment
US buys Argentine pesos
Red Sox Hall of Famer dies
US troops to monitor deal?
Sister Jean dies at 106
Quakes strike Philippines
Hits US ships with port fees
Vance to visit Indiana again
To miss start of NBA season
To build air defense system
To challenge Sen. Collins?
Senate approves defense bill
Dodgers advance to NLCS
Asks for UNSC meeting
Russia strikes Kyiv
CA company recalls pasta
Peru ousts president
Feedback
  • Privacy
  • Terms